Home » Author Archive

Image for Mitek Systems (NASDAQ:MITK) Announces  Earnings Results, Beats Estimates By $0.13 EPS

Mitek Systems (NASDAQ:MITK) Announces Earnings Results, Beats Estimates By $0.13 EPS

Mitek Systems (NASDAQ:MITK) issued its quarterly earnings results on Thursday. The software maker reported $0.23 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.10 by $0.13, MarketWatch Earnings... More of this article »
Image for Limelight Networks (NASDAQ:LLNW) Posts Quarterly  Earnings Results, Beats Estimates By $0.01 EPS

Limelight Networks (NASDAQ:LLNW) Posts Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Limelight Networks (NASDAQ:LLNW) announced its quarterly earnings results on Thursday. The information services provider reported ($0.06) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of... More of this article »
Image for Rari Governance Token Trading 29.5% Higher  This Week (RGT)

Rari Governance Token Trading 29.5% Higher This Week (RGT)

Rari Governance Token (CURRENCY:RGT) traded 4.5% higher against the US dollar during the twenty-four hour period ending at 19:00 PM Eastern on July 31st. During the last seven days, Rari Governance Token has traded 29.5% higher against... More of this article »
Image for Analysts Anticipate NBT Bancorp Inc. (NASDAQ:NBTB) to Announce $0.83 Earnings Per Share

Analysts Anticipate NBT Bancorp Inc. (NASDAQ:NBTB) to Announce $0.83 Earnings Per Share

Equities analysts predict that NBT Bancorp Inc. (NASDAQ:NBTB) will report earnings per share of $0.83 for the current fiscal quarter, according to Zacks Investment Research. Two analysts have made estimates for NBT Bancorp’s... More of this article »
Image for Patten & Patten Inc. TN Has $6.38 Million Position in Bristol-Myers Squibb (NYSE:BMY)

Patten & Patten Inc. TN Has $6.38 Million Position in Bristol-Myers Squibb (NYSE:BMY)

Patten & Patten Inc. TN increased its position in Bristol-Myers Squibb (NYSE:BMY) by 2.6% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 95,415 shares of the biopharmaceutical... More of this article »